# Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)

> **NCT04778813** · PHASE4 · UNKNOWN · sponsor: **Centre national de recherche et de formation sur le paludisme** · enrollment: 1050 (estimated)

## Conditions studied

- Malaria
- Burkina Faso

## Interventions

- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT04778813
- **Lead sponsor:** Centre national de recherche et de formation sur le paludisme
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-01
- **Target enrollment:** 1050 (ESTIMATED)
- **Last updated:** 2021-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04778813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04778813, "Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04778813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*